Spending on cancer care in the U.S. may grow 27% to $207 billion by 2020 if new technologies and treatments add 5% a year to medical costs and trends in survival and prevalence persist, according to a new study from National Institutes of Health.
Spending on cancer care expected to rise
Researchers crunched the figures with a variety of assumptions in an analysis appearing in the Journal of the National Cancer Institute and provided data that can be manipulated to generate custom graphs at costprojections.cancer.gov.
Accounting for just the growth and aging of the population, the researchers project cancer costs would grow from $127.6 billion in 2010 to $158 billion in 2020.
The analysis considers 13 cancer sites for men and 16 for women, and the authors note that the incidence for many cancers is declining while survival rates are rising. The authors project that the number of cancer survivors will increase by nearly a third, from 13.8 million to 18.1 million, in the next decade.
Send us a letter